Considering transparency and value for fairer drug prices

P Webster - 2018 - Can Med Assoc
Six months after the federal government began overhauling how it regulates drug prices, it
has tabled a five-point plan for new regulations. Much of the plan consists of long-familiar …

[CITATION][C] State initiatives to control medication costs—can transparency legislation help?

A Sarpatwari, J Avorn… - New England Journal of …, 2016 - Mass Medical Soc
To evaluate the argument that high drug prices are a fair and necessary reflection of the high
costs incurred to bring a product to market, 10 states have introduced bills that would require …

Fair global drug pricing

JD Campbell, Z Kaló - Expert review of pharmacoeconomics & …, 2018 - Taylor & Francis
On May 11th, the United States (US) executive branch delivered their plan to lower drug
prices [1]. This US blueprint relies on the market to arrive at fair prescription drug prices by …

Fair pricing or pricing for profit?

B Sibbald - 2017 - Can Med Assoc
If you had $500 000, would you provide drugs to one person who has a rare disease for a
year, cure ten people of hepatitis C, or treat 500 with diabetes? This sort of question is …

A Fair Plan for Fairer Drug Prices

S Gottlieb, KK Patel - Health Affairs Forefront, 2016 - healthaffairs.org
As the biological basis of more diseases are fully revealed, and the drugs targeting medical
problems become more focused and effective, more patients are finding themselves on …

[HTML][HTML] Health care price transparency initiatives are all the rage: but burgeoning efforts suffer from myriad shortcomings

S Barlas - Pharmacy and Therapeutics, 2018 - ncbi.nlm.nih.gov
Health Care Price Transparency Initiatives Are All the Rage - PMC Back to Top Skip to main
content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main …

Talkin'about a resolution: issues in the push for greater transparency of medicine prices

B Shaw, J Mestre-Ferrandiz - Pharmacoeconomics, 2020 - Springer
Abstract At the 2019 World Health Assembly, a significant new resolution was agreed by
most countries to start publicly sharing information on the real net prices they pay for …

Revisiting the National institutes of health fair pricing condition: promoting the affordability of drugs developed with government support

A Sarpatwari, AK LaPidus… - Annals of Internal …, 2020 - acpjournals.org
The high cost of many prescription drugs has renewed calls for policies to ensure that
taxpayers' financial contributions to drug development are factored into price setting. The …

Drug pricing and transparency in Europe and the United States: what is it and how does it work?

S Simoens, M Toumi - Expert Review of Pharmacoeconomics & …, 2024 - Taylor & Francis
Introduction As drug prices are viewed to be opaque, there have been increasing societal
demands on policy and decision makers to implement initiatives that promote drug price …

Drug prices: is there a need for transparency?

M Gabay - Hospital Pharmacy, 2016 - journals.sagepub.com
In recent years, the rapid and significant upward trend in prescription drug prices has
become a focus of national debate involving multiple actors including pharmaceutical …